Login

CEOTalks featuring Tomás Córdoba, Presidente y Director General of MetroGAS, discuss industry insights and innovations. 00:10:00

Share On Facebook Share On Twitter

Tomas Cordoba - CEO - MetroGAS

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Navigating Risk: Victor Khosla & Boaz Weinstein Discuss Contrarian Bets at Forbes Iconoclast Summit
00:10:00
Navigating 2022's Investment Challenges: A Mid-Year Review & Outlook | Ben Hockema, Founder, Illuminate Wealth Management.
00:10:00
Streamlining Financial Planning Integration: Insights from John Pastore | Integrated Financial Partners
00:10:00
China's Growing Influence in Emerging Markets: Midyear 2021 Update
00:10:00
How AI is Changing Business|Ankit Jain, Founding Partner, Gradient Ventures
00:10:00
TTG Weekly Update: Market Headlines, Rate Cuts, and Cybersecurity Concerns | Jim Evans, Co-Founder , TTG Financial Inc.
00:10:00
Mr. Nobuo Tanaka, former Executive Director of the International Energy Agency and CEO of Tanaka Global, delivered a special keynote address on energy and the environment on September 4, 2023.
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
PYX Resources Reflects on Transformative Growth Year, Says Oliver Hasler | Oliver Hasler, Chairman , PYX Resources Ltd.
00:10:00
The CEO of Freenet AG discusses the company's strategic ambitions in an interview
00:10:00
The Demands and Realities of CEO Leadership | Strauss Zelnick, Founder, Zelnick Media Capital.
00:10:00
Profit is not always you only care about|Nigel Morris,Co founder,QED Investors

© 2026 Nehu